Standout Papers

Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours Aft... 1999 2026 2008 2017 828
  1. Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset (1999)
    Wayne M. Clark, S. Wissman et al. JAMA

Immediate Impact

5 from Science/Nature 95 standout
Sub-graph 1 of 15

Citing Papers

Reteplase versus Alteplase for Acute Ischemic Stroke
2024 Standout
Hallmarks of neurodegenerative diseases
2023 Standout
24 intermediate papers

Works of Kenneth P. Madden being referenced

Dose Escalation Study of the NMDA Glycine-Site Antagonist Licostinel in Acute Ischemic Stroke
1999
Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset
1999 Standout
and 3 more

Author Peers

Author Last Decade Papers Cites
Kenneth P. Madden 1465 49 531 625 614 6 1.6k
Edward C. Jauch 1428 17 594 687 502 6 1.6k
Yasir Al‐Rawi 1529 8 675 854 432 11 1.7k
Lars Herrman 1467 14 551 774 480 9 1.7k
Rosie Miller 1125 17 407 490 449 18 1.6k
Esteban Santamarina 965 11 650 555 177 13 1.4k
Ioannis Christou 1568 15 1045 1166 282 16 1.8k
Christiana E. Hall 994 61 580 311 346 17 1.5k
Janice Carrozzella 1564 38 1112 920 433 29 2.0k
Tracey Baird 1403 61 748 545 479 22 2.1k
Ruediger von Kummer 1457 28 800 926 320 33 1.8k

All Works

Loading papers...

Rankless by CCL
2026